The Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) were used to assess depression and anxiety. A score≥5 points was defined as elevated depression or anxiety. High hs-CRP was defined as ≥3mg/L. Follow-up was performed 2 years after the patients were...
Mood: Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) Symptoms of depression will be assessed using the PHQ-9 [44], which is a nine-item questionnaire generating scores ranging from 0 to 27. A score of ≥ 10 is indicative of probable depressive disorder....
A score 鈮 10 on the PHQ-9, GAD-7 and PHQ-ADS scale was considered having clinically meaningful depression, anxiety and distress symptoms. Factor structure of the combined PHQ-ADS scale was validated using confirmatory factor analysis, and three models were tested: a one-factor, a two-factor...
Several suggestive interactions between inflammation factors and COVID‐19 clinical phenotypes were detected for PHQ‐9 score, such as CRP/SII×Hospitalized/Not_Hospitalized in women group and CRP×Hospitalized/Unscreened in age >65 years group. For GAD‐7 score, we also found several suggestive ...
After 6 months intervention, mean changes from their corresponding baseline values for the climacteric syndrome score, fatigue score, PHQ-9 depression score and GAD-7 anxiety score in isoflavone combined with calcium group were significantly lower than those of calcium group and control group(p<0.05...
The scores of PHQ-9 (7.83±1.71) and GAD-7 (6.38 1.09) in the observation group were lower than those in the control group (P < 0.05). The frequency of drinking (2.15 0.56), intensity of drinking (2.33±0.52), duration of drinking (2.11±0.51), ability to resist drinking (2.09±...
Objectives The Patient Health Questionnaire-4 (PHQ-4; Kroenke, 2009) is a composite instrument constructed from the GAD-2 and PHQ-2 questionnaire assessments of depression and anxiety symptoms. We sought to build on prior validation of the instrument by evaluating the reproducibility of the PHQ-4...
The secondary outcome metrics were anxiety (GAD-7,7-item Generalized Anxiety Disorder scale), Depression Symptoms (PHQ-9,Patient Health Questionnaire-9), pain catastrophizing (PCS, Pain Catastrophizing Scale) and Self-efficiency (PSEQ, Pain Self-Efficiency Questionnaire). Results:A total of 37 ...
Secondary outcomes included ISI response at week 4, as well as ISI, Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder 7-item (GAD-7) scores at baseline and weeks 1, 2, 3, 4, and 6. Additionally, Pittsburgh Sleep Quality Index (PSQI) scores were evaluated at ...